BACKGROUND: Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV and has the potential to significantly impact the HIV epidemic. Given limited resources for HIV prevention, identifying PrEP provision strategies that maximize impact is critical. METHODS: We used a stochastic individual-based network model to evaluate the direct (infections prevented among PrEP users) and indirect (infections prevented among non-PrEP users as a result of PrEP) benefits of PrEP, the person-years of PrEP required to prevent one HIV infection, and the community-level impact of providing PrEP to populations defined by gender and age in western Kenya and South Africa. We examined sensitivity of results to scale-up of antiretroviral therapy (ART) a...
BACKGROUND: HIV remains a leading contributor to the disease burden in sub-Saharan Africa, with adol...
BACKGROUND: Pre-exposure prophylaxis (PrEP), a WHO-recommended HIV prevention method for people at h...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored a...
INTRODUCTION: The new WHO guidelines recommend offering pre-exposure prophylaxis (PrEP) to people wh...
In 2017, Kenya became one of the first African countries to provide pre-exposure prophylaxis (PrEP) ...
Introduction: Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan...
Background: In sub-Saharan Africa, adolescent girls and young women (AGYW) are at high risk of acqui...
BACKGROUND:Young women account for a disproportionate fraction of new HIV infections in Africa and a...
OBJECTIVES: New HIV infections remain higher in women than men in sub-Saharan Africa. Preexposure pr...
BACKGROUND: Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-c...
Pre-exposure prophylaxis (PrEP) for HIV prevention has evolved significantly over the years where cl...
Oral pre-exposure prophylaxis (PrEP) significantly reduces human immunodeficiency virus (HIV) acquis...
BACKGROUND: Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-c...
Adolescents and young women, particularly in South Africa, are at increased risk of HIV acquisition....
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: HIV remains a leading contributor to the disease burden in sub-Saharan Africa, with adol...
BACKGROUND: Pre-exposure prophylaxis (PrEP), a WHO-recommended HIV prevention method for people at h...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored a...
INTRODUCTION: The new WHO guidelines recommend offering pre-exposure prophylaxis (PrEP) to people wh...
In 2017, Kenya became one of the first African countries to provide pre-exposure prophylaxis (PrEP) ...
Introduction: Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan...
Background: In sub-Saharan Africa, adolescent girls and young women (AGYW) are at high risk of acqui...
BACKGROUND:Young women account for a disproportionate fraction of new HIV infections in Africa and a...
OBJECTIVES: New HIV infections remain higher in women than men in sub-Saharan Africa. Preexposure pr...
BACKGROUND: Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-c...
Pre-exposure prophylaxis (PrEP) for HIV prevention has evolved significantly over the years where cl...
Oral pre-exposure prophylaxis (PrEP) significantly reduces human immunodeficiency virus (HIV) acquis...
BACKGROUND: Approaches that allow easy access to pre-exposure prophylaxis (PrEP), such as over-the-c...
Adolescents and young women, particularly in South Africa, are at increased risk of HIV acquisition....
Background: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents ne...
BACKGROUND: HIV remains a leading contributor to the disease burden in sub-Saharan Africa, with adol...
BACKGROUND: Pre-exposure prophylaxis (PrEP), a WHO-recommended HIV prevention method for people at h...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored a...